Gmp Synthesis Chemistry Services CRO, Onyx Scientific, Reports Increased Small Scale Production for Phase I and II Clinical Studies
Onyx Scientific manufacture high value intermediates and APIs to GMP-compliant standards for both phase I and phase II clinical studies.
View as PDF
September 2, 2010 (FPRC) -- Internationally renowned, contract research organisation Onyx Scientific, is pleased to announce the continued growth of its small-scale GMP custom synthesis services for development APIs (Active Pharmaceutical Ingredients)
Commenting on the growing success of its small-scale GMP synthesis services, CEO, Dr Tony Flinn says 'our success is due to open communication and a highly responsive scientific team, who are able to lower the cost of a GMP process by suggesting alternative chemical pathways to develop an API product'.
Denise Bowser, Commercial Director, Onyx Scientific adds, 'Newly patented APIs are driving the demand for quality GMP compliance and itís here we excel, in streamlining GMP-approved processes and difficult-to-synthesise APIs. Our compliance standards minimise impurities, reduce costs and significantly improve timelines for phase I and II clinical studies.
Denise adds. 'Onyx has earned the enviable reputation as one of the hardest working chemistry service providers with world-class GMP synthesis capability to harmonise:
Selection of the starting materials
Mapping of critical manufacturing steps
Process parameters and controls for product quality
Capacity to reduce or remove impurities
Assessment of process robustness
Proof that methods are suitable for validation and scale up
Identification and control of critical intermediates
Certificates of analysis
Onyx Scientificís GMP kilo-lab facility boasts flexible isolation rooms, a class 100,000 clean-room and a variety of vessel sizes up to 100 litres enabling ultimate technology transfer to manufacturing scale and access to an extensive range of analytical services with expert GMP regulatory guidance provided as standard'.
In addition to GMP synthesis and scale-up, Onyx Scientificís breath of services include solid-form polymorph screening, salt selection, custom synthesis, process development and lead optimisation.
The Onyx Scientific service model provides both dedicated FTE and fee-for-service resources, with full transparency and flexibility to switch resource on and off as needed even at short notice
MHRA certified, Onyx Scientificís state-of-the-art facility conforms to international GMP standards for the development and production of active pharmaceutical ingredients.
Send an email to Sue Jones of Onyx Scientific Ltd
+44 (0) 191 516 6516
Recent Press Releases By The Same User
Gmp Synthesis Chemistry Services Organisation, Onyx Scientific, Announce Increased Demand for Early-phase Investigational New Drug (IND) Development (Wed 23rd Mar 11)
Custom Synthesis Chemistry Services CRO, Onyx Scientific, Hails the Success of Its Solid-state Polymorph Screening Services (Tue 28th Dec 10)
Solid-state Chemistry Services CRO, Onyx Scientific Reports Increased Demand for Polymorph Screening, Salt Selection and Crystallization Studies (Thu 11th Nov 10)
Polymorph Screening Chemistry Services CRO, Onyx Scientific, Announces the Continued Strong Growth of Its Solid-state Services (Tue 6th Jul 10)
Onyx Scientific Grows API GMP Synthesis Contract Chemistry Services (Fri 9th Apr 10)